Covid-19 Update

Eleanor Laing Excerpts

Monday 15th November 2021 Commons Chamber

[Sajid Javid]

The second doses for 16 and 17-year-olds will be available from Monday next week. I also join my hon. Friend in thanking, in particular, the local schools for all the work that they have done in Aylesbury to help with that.

[Madam Deputy Speaker (Dame Eleanor Laing)]

And finally, I call Jim Shannon.

[Jim Shannon (Strangford) (DUP)]

I thank the Secretary of State for his clear commitment to protecting all citizens in the United Kingdom where the control is. I am a type 2 diabetic. This Saturday, between 2 pm and 3 pm, through my local surgery, I will receive my covid booster, as will other priority cases as well. Can the Secretary of State outline what discussions have taken place to ensure that, before over-40s are able to access their booster jabs, the vulnerable groups of all ages, including diabetics, can access theirs in a timely manner throughout the UK? Decisions taken in this House set the marker for other regions to follow, including Northern Ireland.

Menopause (Support and Services) Bill

Eleanor Laing Excerpts

2nd reading
Friday 29th October 2021 Commons Chamber

[Esther McVey (Tatton) (Con)]

I, too, congratulate the hon. Lady on bringing forward this issue and pursuing it in such a constructive, positive and enthusiastic way not just in the House but outside it too, and on the points she raises about the stigma attached to the menopause and the idea that women of a certain age are maybe past their prime. Absolutely not. People need to know that women’s lives actually might begin at 50. Thank you for what you have done and, I understand, for your constructive work with the Government. What you are doing today is a most important step forward—

[Madam Deputy Speaker (Dame Eleanor Laing)]

Order. I cannot let the right hon. Lady, who is a senior Member of the House, say “you” when she means “her”. Could she just say it again, just to please me?

[Esther McVey]

I was carried away by the excitement of the moment, but you are quite right, Madam Deputy Speaker. The hon. Lady has done so much and will earn the gratitude of the whole country for what she is doing with this positive step forward today.

--- Later in debate ---

[Seema Malhotra]

I, too, just want to pick up on the point that my hon. Friend made about women and the workplace. We know that, according to the Centre for Ageing Better, 800,000 people over 50 were wanting to work more and were under-employed—that was the case a year ago, at least. Does she agree—

[Madam Deputy Speaker (Dame Eleanor Laing)]

Order. The hon. Lady has already had one intervention, which was very long. I allowed that, but her second intervention is heading towards being very long and I cannot construct this debate like that. About 30 people wish to speak this morning. I am sure that the promoter of the Bill wants to make sure that as many people as possible get to speak, but that she also will not want to talk out her Bill. I hope that those who support the Bill will not make long interventions and long speeches, because otherwise the Bill will be talked out and we will not achieve the result we are intending to achieve. So I ask for brevity, please, on all sides.

[Carolyn Harris]

Thank you, Madam Deputy Speaker. May I suggest that my hon. Friend and I have a conversation outside the Chamber, where we can expand on what she is seeking to establish?

As women reach this stage in their lives, understanding their own bodies and having support in all areas of their lives is crucial, but it is clear that we have a long way to go. That is why the Bill calls on the Secretary of State to lay before Parliament a United Kingdom, cross-party, cross-Government strategy on menopause support and services that will incorporate all the areas I have spoken about.

--- Later in debate ---

[Carolyn Harris]

With the leave of the House, I thank the Minister and the Clerks. Wonderful women—thank you! What has happened today is only the beginning, but we can do such great things together. It is all about looking after women. I have just been told that the Welsh Government have also announced that they will be putting mandatory lessons for young people on the national curriculum, and will be delivering a pathway for menopausal women. The revolution has made a big difference. We are keeping women wonderful. Thank you all for your speeches and your time.

I beg to ask leave to withdraw the motion.

[Madam Deputy Speaker (Dame Eleanor Laing)]

The hon. Lady appears to have achieved her objective.

Motion and Bill, by leave, withdrawn.

Baby Loss Awareness Week

Eleanor Laing Excerpts

Thursday 23rd September 2021 Commons Chamber

[Madam Deputy Speaker (Dame Eleanor Laing)]

This has been a very moving and, indeed, important debate not just because of the subject matter itself but because it reflects the progress that we have made as a modern legislature, in that the matters we now deal with in this House, on the Floor of this Chamber, truly reflect the concerns and experiences of all the people we represent.

I hardly need to put the Question, but I am obliged to do so.

Question put and agreed to.

Resolved,

That this House has considered Baby Loss Awareness Week.

NHS Update

Eleanor Laing Excerpts

Wednesday 21st July 2021 Commons Chamber

[Madam Deputy Speaker (Dame Eleanor Laing)]

Just before the Minister responds, I will say that Mr Speaker will be annoyed, to say the least, that the hon. Member for Tooting (Dr Allin-Khan) did not receive the statement from the Minister in time. The Minister did apologise at the beginning of her remarks, so I have noted that apology and we do not have to go any further on that, but I have also noted what the hon. Lady has said.

[Helen Whately]

Thank you, Madam Deputy Speaker. I reiterate my apology to the hon. Lady for the late sight of the statement and thank her for her invitation to join her, but I will say that I am shocked by some of the language that she uses. I would just say—[Interruption.]

[Madam Deputy Speaker]

Order. The hon. Member for Tooting must not shout at the Minister across the Dispatch Box. She was heard, and the Minister must be heard.

[Helen Whately]

What we say in this Chamber is clearly important and it has ripples beyond the Chamber, so I for one consider the tone of what we say to be extremely important. The hon. Lady spoke about pay for NHS staff. As she knows, the Government asked for recommendations from the NHS pay review bodies. The Government are rightly seriously considering those recommendations, and we will be responding as soon as we possibly can. She also knows that last year the Chancellor committed to NHS staff receiving a pay rise at a time when there is a wider freeze on public sector pay, recognising the extraordinary lengths that NHS staff have gone to during the pandemic.

The hon. Lady talked about the pressures on NHS staff, which she and I know go back a long way, but yes, of course they have been so much greater during the pandemic. We know that NHS staff have gone above and beyond, time and again, during the pandemic to care for patients. Recognising that, and knowing that that has been happening throughout the pandemic, I have worked with NHS England, and particularly the people team there, to put in place all possible support for staff during these difficult times. That includes practical support with some of the day-to-day challenges of working shifts and the extra disruption to people’s lives and home lives during the pandemic, as well as mental health support, including setting up 40 new mental health hubs for staff, which I have heard from staff on the frontline are really making a difference. In fact, some of these things are making the NHS a better place to work for the future, and we should try to continue some of the improvements to mental health support for staff, recognising the importance of this to people who are doing extremely challenging jobs.

I also say to the hon. Lady that we now have record numbers of staff in our NHS. We have over 300,000 nurses, as I said earlier—around 9,000 more nurses than a year ago—and record numbers of doctors, so we have more staff in our NHS. We are also seeing a huge interest in NHS careers. For instance, we have seen a 21% rise in applications to UCAS for nursing degrees this year, which comes on top of a rise last year as well. I welcome the fact that so many people now want to join our NHS to support it, and I am determined that we as a Government will continue to support our NHS workforce in the weeks and months ahead.

--- Later in debate ---

[Helen Whately]

The hon. Lady is absolutely right that retention is vital to us for maintaining the staff that we have in the NHS. For instance, to achieve our 50,000 more nurses for the NHS, there will be a combination of new domestic recruitment, staff training to become nurses, international recruitment, but also retaining the nurses that we have, which is a really important part of it. That is why we worked so hard during the pandemic to support NHS staff to stay with the NHS. What we have seen—I am truly grateful to many staff for this—is people sticking with the NHS during this time. Some staff have even delayed their retirement in order to help the NHS through the pandemic. Looking ahead, we must be ready to continue supporting staff, including, for instance, staff who are nearing the end of their careers, making sure that, if they want to work a bit differently—more flexibly for instance—that should be available. That is one thing among a whole host of things that we are doing in order to support the retention of staff.

[Madam Deputy Speaker (Dame Eleanor Laing)]

I must just say to the House that the hon. Member for Hackney South and Shoreditch (Meg Hillier) is not the only Member this week and in recent weeks who has addressed the Minister as “Minister”. I am sorry to pull up the hon. Lady. I am doing it to her because I know that she can take it and will not be upset by my criticising her. I am rather more gentle with the new Members, so I thank the hon. Lady for helping me in this by allowing me to use her as an example. When a Member asks a question, you do not say, “Minister, are you going to do this?” You say, “Madam Deputy Speaker, or Mr Speaker, does the Minister understand that she must do this?” We must not lose sight of that because it changes the way in which dialogue occurs in this place. Just because it is hot, the end of term and we have covid problems does not mean that we let our standards fall.

[Mr Steve Baker (Wycombe) (Con)]

On Monday, Sky News was among those who reported that frontline health workers in England are to be spared self-isolation rules in an emergency move to tackle the pingdemic that has triggered an NHS staffing crisis. I am very pleased, because, of course, the NHS has a special place in all our hearts and in all our constituents’ hearts, but so, too, does food in the supermarkets and on our tables, and the capacity of businesses to recover, particularly theatres, which have been in the news. What will my hon. Friend do to ensure that everyone is freed from this great curse of the pingdemic, which is keeping us from our recovery?

--- Later in debate ---

[Helen Whately]

It is very good to hear that Wirral Council is supporting social care workers in its area. Local authorities are a crucial part of our work in social care reform and they have so many of the direct relationships with the care providers who are providing that social care. We are absolutely committed to bold, ambitious reforms for social care. As the hon. Lady knows very well, we will be bringing those forward during this year.

[Madam Deputy Speaker (Dame Eleanor Laing)]

I ought to conclude the statement here, because we are running way behind time. However, I appreciate that Members have important questions to ask and that the Minister will want to answer them. But I ask for much greater speed and brevity, because otherwise it is not fair to people who are waiting for us to come on to the next item of business. I call Dr Ben Spencer.

[Dr Ben Spencer (Runnymede and Weybridge) (Con)]

Thank you, Madam Deputy Speaker. Before I ask my question, may I declare an interest, in that my wife works in the NHS?

I thank the Minister for her statement, particularly on supporting our workforce. When I speak to local health leaders they tell me that the workforce are tired—they have been dealing with covid for the past 18 months, and they are worried that they will have to lurch from covid into tackling 150% of the covid backlog. What reassurance can the Minister give health staff working in my constituency that there will be a sustainable transition from dealing with the pandemic to dealing with all the backlog and consequences as a result of it?

--- Later in debate ---

[Helen Whately]

No, I do not think that is the case.

[Madam Deputy Speaker (Dame Eleanor Laing)]

Finally, we go by video link to Peter Bone.

[Mr Peter Bone (Wellingborough) (Con) [V]]

Thank you, Madam Deputy Speaker; we much appreciate you extending this session.

Before any major change is made in the NHS, there is a full impact assessment done to see how it affects wider society. Would the Care Minister be able to say when last week, when the statutory instrument on compulsory vaccination of care staff was put before the House, she had the opportunity to read the SI, the explanatory notes and the full impact assessment? If there was no full impact assessment, why did the Government proceed in laying it before Parliament?

Public Health England: Relocation to Harlow

Eleanor Laing Excerpts

Monday 12th July 2021 Commons Chamber

[Robert Halfon (Harlow) (Con) [V]]

It is a huge honour to be doing this debate under your chairmanship today, Madam Deputy Speaker, and I thank Mr Speaker for granting this debate. Today I would like to update the House on the desperate need for the creation of a new state-of-the-art public health science campus that is fit for the 21st century. This debate is timely as we seek to recover from the devastating covid-19 pandemic that has plagued us for far too long.

In September 2015, the then Chancellor, George Osborne, announced that the Government would be investing £350 million to create world-leading public health laboratories in my constituency of Harlow, Essex. The original intention was for Public Health England’s headquarters and scientific functions to be relocated to our town. I pay special tribute to you, Madam Deputy Speaker, my hard-working constituency neighbour. You are not just a Deputy Speaker, but the right hon. Member for Epping Forest (Dame Eleanor Laing), and you have worked hard with me for a long time on supporting Public Health England. I give thanks to my hon. Friend the Member for Brentwood and Ongar (Alex Burghart), and to my hon. Friend the Member for Hertford and Stortford (Julie Marson), with whom I share a constituency office. She has done so much on this issue. I know she will be speaking tonight, and I strongly welcome her solid support, as I do yours, Madam Deputy Speaker, for the move of Public Health England’s successor body to Harlow.

I understand that Public Health England is being disbanded and that the organisation is due to be replaced by the newly formed UK Health Security Agency. I have been well assured that this new organisation will also require modernised laboratories. Previous problems have not turned to dust. The current facilities available at Porton Down and Colindale remain exhausted, burned out and ultimately no longer fit for purpose. Significant funding has already been committed to the Harlow site—I understand that the total amount of money spent on project thus far is approaching £250 million.

In a vote of confidence in response to my recent parliamentary question, the Minister explained that a further £120 million-worth of investment has been agreed for the period spanning 2021 to 2022 in Harlow. That shows a real commitment from the Government. I thank the Minister, the Department of Health and Social Care, and in particular the former Health Secretary, my right hon. Friend the Member for West Suffolk (Matt Hancock), for the continued support for the project and for my constituency of Harlow.

Not only has significant investment taken place, but the plan for the creation of a public health science campus in Harlow is now mature and shovel-ready. Considerable site demolition work has been completed. The buildings have now been stripped to their core and the drainage and power systems are beginning to be installed. Contracts are being drawn up and construction proper could start this year.

In this debate, I would like to outline three reasons why the campus remains necessary and why Harlow is still the best location for the Government’s investment. I am pleased to have met Health Ministers, the Chancellor and senior officials at Public Health England to discuss these matters over the past months. First, the need for updated facilities has become even more important given the current public health context. We must learn lessons from the covid-19 pandemic. We should be looking to the future and onwards to the horizon as we climb down from the coronavirus mountain. We cannot afford to be too cautious. Given that there will be ever-increasing public health spending, the Harlow plant provides excellent value for money. Furthermore, the Harlow project has been designed with the threat of a novel pandemic infection in mind, as has been emphasised on the Government’s own website, which states:

“Early learnings from COVID-19 clearly show the importance of an integrated public health response and the need for rapid sharing of data, information, new laboratory tests and other innovations, coordinated and led from centres like Harlow.”

Those learnings have strengthened the case for the campus, which will place Harlow as one part of the public health system for the development and application of a range of public health interventions. Those can then be adopted across the country.

The construction of a new campus with world-leading laboratory facilities will surely go a long way in improving our resilience and ensuring preparedness for future pandemics. The project will provide a reassuring message for us to give the nation while managing continued uncertainty and scrutiny. This hub could be a shining beacon of hope in the stormy sea from which we are emerging.

Secondly, Harlow’s location within the area covered by the UK Innovation Corridor makes it the ideal place for the creation of such a campus. The London-Stansted-Cambridge corridor is a driver for growth in data sciences as well as life sciences and that sets it off as a unique set of opportunities. Creating the campus in Harlow will mean that our nation’s core microbiology, epidemiology, genomics and data science capabilities will be close to major universities in Cambridge, Essex, Hertfordshire and north London, and the Wellcome Sanger Institute as well as leading life science multinational companies such as GlaxoSmithKline and AstraZeneca. The east of England could be set to become the public health science capital of the world. We could lead the way in research, science and technology.

The importance of the project was even referenced in the UK Innovation Corridor’s submission to the 2020 spending review. It stated:

“The creation of a new public health science campus represents an enormous recognition of the region as being at the forefront of UK science, research and innovation. It is integral to enabling the Innovation Corridor to fully realise its potential in positioning the UK as a scientific superpower.”

In addition, Harlow itself has a tradition of life science and public health investment. The proximity of the campus to the town’s enterprise zones and science park makes Harlow and the science hub the best location for business and research partnerships. The new Harlow hospital, expected by 2025, will also create greater opportunity for health science partnerships, skill sharing and research.

Thirdly, the project will bring significant benefits to the Harlow constituency and surrounding area and fit neatly with the Government’s commitment to level up disadvantaged areas. The Government should be looking to distribute research capacity widely across the UK, rather than concentrating investment in the big capital cities.

Harlow is the second most deprived town in Essex and has some of the most deprived neighbourhoods in the country. Even before the pandemic, jobs, growth and educational attainment had stalled. Much of this is rooted in a new town legacy of ageing infrastructure, poor housing stock and poor perceptions of place, by which I mean disused buildings, some levels of antisocial behaviour and low economic capital. The Government are committed to a levelling-up agenda. I have worked hard to ensure that the Harlow constituency has received great investment. Harlow has been given £81 million for the M11 junction 7a, hundreds of millions for our new Harlow hospital, major investment for our enterprise zone and science park, and most recently £23.7 million as a result of the towns fund bid.

Further to that, Harlow College, one of the finest further education colleges in England, is also bidding, with other colleges in Essex, for a new institute of technology. The bid comes on top of a £2.5 million upgrade of the college and the creation of a £12 million advanced manufacturing centre. Public Health England is also helping to provide skills for Harlow and the surrounding area with its construction hub, which was opened at Harlow College in October 2019. We have further exciting developments taking place, such as the Harlow and Gilston garden town project, which could bring thousands of new homes. It is reliant to an extent upon the creation of a new public health campus in Harlow, as that would bring jobs to sustain this new influx of people.

The creation of a new public health science campus in Harlow would be the golden thread that would tie all this investment together; it is the linchpin upon much else rests. The project represents an opportunity to drive forward Harlow’s growth strategy and address some of the socioeconomic challenges faced by our town and the surrounding areas. The impact that this project will have on Harlow is clear, as it has been estimated that it will create 2,900 gross permanents jobs and generate about £80 million a year across Essex, through employment, skills, STEM— science, technology, engineering and maths—local procurement and support for the local economy.

Madam Deputy Speaker, your place in the Chair tonight signifies your vote of confidence in and hard work for Public Health England. I welcome the Government’s investment in PHE and the vote of confidence of £120 million this year in the Harlow plan. Clearly, things will be different with the new UK Health Security Agency. However, for the reasons I have outlined, the Government could not have made a better decision than by investing in Harlow. First, the public health context and the need for new facilities makes this project ever more crucial. Secondly, Harlow’s location is second to none; our town is part of the innovation corridor and has a long history of life science investment. Thirdly, this project is an essential part of the Prime Minister’s levelling-up agenda and will transform our town by bringing jobs, skills, growth and opportunity.

[Madam Deputy Speaker (Dame Eleanor Laing)]

I thank the right hon. Gentleman for his kind words, for pointing out how extremely important this project would be for my constituency of Epping Forest, which is next door to his constituency of Harlow, and for setting out the case so well.

Covid-19 Update

Eleanor Laing Excerpts

Monday 12th July 2021 Commons Chamber

[Mr Mark Harper]

Further to that point of order, Madam Deputy Speaker. In intending to be helpful to those on the Treasury Bench, I have noticed, looking at the said regulations, that they do not actually come into force until 16 weeks after they are approved by the House. It seems to me that in four months there is plenty of time for the Government to produce the relevant information for the House and for the House to take a decision, with no detriment at all to the health and safety of anyone in our care homes.

[Madam Deputy Speaker (Dame Eleanor Laing)]

I thank both hon. and right hon. Gentlemen for their points of order. I am sure the House is well aware that it is not a matter for the Chair. I will not spring it on the Secretary of State for him to give an answer on this operational matter, but Mr Speaker usually observes that it is helpful to the House for Members to have as much information as possible before them when a matter of importance is to be considered.

[Sir Christopher Chope]

Further to that point of order, Madam Deputy Speaker. The explanatory memorandum falsely asserted that the full impact assessment is available. Why was the House misled in that way?

[Madam Deputy Speaker]

Once again, the hon. Gentleman knows that I cannot answer that question, because what is said by Ministers and their Departments is not a matter for the Chair. However, if it were to be the case that a spokesman for a Minister had suggested that something had happened that had not happened, and on which Members were trying to rely and could not rely, Mr Speaker would take a very dim view of that. It is better if Ministers make sure that their Departments give as much information as possible to Members ahead of discussions.

[Jonathan Ashworth]

rose—

[Madam Deputy Speaker]

Is it further to that point of order?

[Jonathan Ashworth]

It is indeed further to that point of order, Madam Deputy Speaker. I rise to reinforce the point raised by the hon. Member for Christchurch (Sir Christopher Chope) and the right hon. Member for Forest of Dean (Mr Harper). What the House is being asked to decide tomorrow is whether to proceed with compulsory vaccination for a certain section of the healthcare workforce. We have not had compulsory vaccination in this country since the 19th century, when it was tried and abandoned. This is an incredibly serious intervention. Is there a procedure by which the House can delay coming to a decision tomorrow until the assessment is published?

[Madam Deputy Speaker]

I do not believe there is such a procedure, as the matters on the Order Paper are a matter for the Government. I note that the Lord President of the Council has just come into the Chamber, so he will undoubtedly hear the end of this matter, although he did not hear the beginning of it and so I would not dream of asking him to comment. If the hon. Gentleman is suggesting that a delay should be put in place, I am sure he will be able to make reference to that when he has the opportunity to do so tomorrow.

[Sir Desmond Swayne]

On a point of order, Madam Deputy Speaker. Will it be possible—will it be in order—to question the Leader of the House about this matter, as he is about to make a statement about tomorrow’s business?

[Madam Deputy Speaker]

No. The right hon. Gentleman is fond of short questions and short answers, and that is my short answer. The statement that will be made after a brief suspension of the House, which I am about to announce, by the Lord President of the Council, will be, I understand, on a very narrow and specific matter, and I will allow questions only on that very narrow and specific matter. Having said all that, I am quite sure that the Secretary of State and those on the Treasury Bench have taken note of what has been said over these past minutes. [Interruption.] I am pleased to see that the Secretary of State has indeed taken note, so hon. Members have achieved what they set out to achieve. I shall now suspend the House in order that arrangements can be made for the next item of business.

Independent Medicines and Medical Devices Safety Review

Eleanor Laing Excerpts

Thursday 8th July 2021 Commons Chamber

[Cat Smith (Lancaster and Fleetwood) (Lab) [V]]

As I am chair of the all-party parliamentary group on valproate and other anti-epileptic drugs in pregnancy, my comments are on that issue. However, I just want to note the harm done, the hurt caused and the justice needed for victims of surgical mesh and Primodos, who are in a similar position to those who have been harmed by sodium valproate.

One of the common threads that runs through all three campaigns is the way in which, more often than not, it is women who are the victims and it is women’s concerns that have been dismissed. Justice, frustratingly, always seems just out of reach.

One year on from the report’s publication, we really are not much further forward when it comes to sodium valproate. NHS England wrote recently to all women and girls aged 12 to 55 who are currently prescribed sodium valproate, reminding them of the risks of taking it while pregnant. That is a step in the right direction, but it has taken a year. One letter is not going to resolve the issue. The Government really must explain what further action will be taken and over what timescale.

Baroness Cumberlege’s report included nine general recommendations, in addition to a number of specific recommendations on sodium valproate. In January, the Minister provided the Government’s initial response to the recommendations. However, she only responded to the general recommendations and not the specific recommendations on sodium valproate. The Government have since stated on a number of occasions that they will respond in full later this year. Do the Government still plan to make a full response this year and will they address the report’s specific recommendations on sodium valproate?

I have a few brief comments about recommendations 3, 4, 5 and 9 of the report, before turning to the specific recommendations on sodium valproate. I would appreciate an update from the Minister.

Recommendation 3, which is for a new independent redress agency for those harmed by medicines and medical devices, has not been implemented, and it appears that the Government are unwilling to do so. May I express how hugely disappointing that is, given the avoidable harm that so many families have experienced? The case for an independent redress agency remains strong. Other countries have successfully set up an agency without such a mechanism, and people who have suffered avoidable harm following healthcare treatment have no option but to go to court, which is such a lengthy, expensive, confrontational and stressful process.

On recommendation 4, although the Government have stated that they are carefully considering a redress scheme for those harmed by sodium valproate, no further progress has been made. Again, I feel so disappointed, and I know that the families affected share that feeling. Patients who have suffered avoidable harm need help and support now, and actually we owe it to them. That may take the form of additional financial support, above and beyond that to which they are already entitled via welfare benefits and respite care. The frustrating thing is that many have already waited decades for help. What progress is being made to establish a redress scheme for those affected by sodium valproate?

On recommendation 5, again there has been no progress on establishing any specialist centres for those adversely affected by medicines taken during pregnancy. The Department of Health and Social Care appears to take the view that such centres are not needed. I therefore call on the Government to commit to introducing a network of such specialist centres, in recognition of the additional support and care that those affected require.

Recommendation 9 is that the Government should immediately set up a taskforce to implement the review’s recommendations. The Government have been quite clear that they have no plans to establish such a taskforce. The 14-person patient reference group that has been established had a series of meetings this year and will publish its findings shortly. I look forward to reading them, but the group is only able to provide feedback on proposals, whereas a taskforce would have been able to implement the recommendations. The Government really need to explain how they intend to keep patients fully involved as they move forward with full implementation of the report.

On the sodium valproate recommendations, the Government have not responded directly to any of these recommendations, and quite frankly they need to. More importantly, they need to implement them. On the recommendation that a clear process should be agreed to ensure that women can receive counselling related to their epilepsy treatment and contraception choices, at the moment it is a postcode lottery, so what progress is being made to ensure that women and girls with epilepsy have access to pre-conception counselling on epilepsy medicines and contraception?

On the recommendation that information should be collected to identify those already affected by exposure to valproate to ensure that they have access to diagnosis and support and plan their service provision, it is still not sufficient, especially without the redress scheme in place. May we have a response to that recommendation, please?

On the recommendation that a prospective registry should be established for all women on anti-epileptic drugs who become pregnant, and to include them in mandatory reporting of data relating to them and their children, such a registry could be expanded to collect data on paternal effects as well, but at the moment we are just looking at valproate. The valproate registry has been established, and it has been confirmed that other epilepsy medicines will be included, but that has not happened yet. It needs to be expanded to include those other epilepsy medicines as a matter of urgency, because we already know that anti-seizure medication is causing problems during pregnancy.

On the recommendation about stakeholders continuing to work with the patient groups to monitor and improve the pregnancy prevention plans and look at the next steps, all women and girls of childbearing potential have been written to, as I said at the start of my contribution, but we really need to do so much more to improve the PPP. It is important that a balance be found that allows women to make a choice about their treatment and care, while limiting the number of pregnancies exposed to sodium valproate and other harmful epilepsy medicines. May I ask the Minister what progress has been made in making improvements to the PPP?

The final recommendation on sodium valproate is:

“Clinicians should continue to follow guidance regarding prescribing of valproate and alternatives”.

Although further measures have been introduced to communicate the need for that, it is unclear—perhaps the Minister can shed some light—whether or not it is happening in practice, particularly given past concerns about the lack of communication with women and girls. That is a huge concern for me, as I know it is for many of the campaigners involved.

This is not the first time that I have raised the issue in the House. I put on record my thanks to my constituent Janet Williams and her fellow campaigner Emma Murphy for bringing the scandal to my attention in my first few weeks as an MP. Since then, I have learned so much about sodium valproate and epilepsy. I also put on record my thanks to Daniel Jennings from Epilepsy Action for his support in keeping me abreast of this and other issues that people with epilepsy face.

The challenges that women seeking pregnancy face while managing their epilepsy are not just about sodium valproate. Evidence shows that there are a number of other anti-epilepsy drugs that can cause preventable disabilities in babies when taken by their mothers. We must not forget the women impacted by other anti-epilepsy drugs. We cannot go on seeing history repeat itself. Anyone watching this debate who is in that situation might want to seek out the Epilepsy Society’s “Safe Mum, Safe Baby” campaign.

The Government need to consider funding research into safer epilepsy medicines so that babies will not be born with preventable disabilities caused by their mothers’ life-saving drugs. Some important progress has been made, but there are far too many areas in which we are still waiting for action and further response from the Government. It is deeply concerning that the Government have so far chosen not to respond to the specific recommendations on sodium valproate, because it took six months before they produced their initial response to the Cumberlege report, and after a further six months we are still waiting for their full reply.

[Madam Deputy Speaker (Dame Eleanor Laing)]

Before we go any further, may I make an appeal to hon. Members who are speaking from home to remember that those who are here in the Chamber still have to get back to their constituencies this evening—and that usually that which can be said in 10 minutes can be said more effectively in five or six?

[Peter Gibson (Darlington) (Con) [V]]

Thank you, Madam Deputy Speaker; you will pleased to know that I will probably speak only for approximately three minutes, having got used to that time limit.

I am glad to have the opportunity to speak in today’s important debate, one year on from the publication of Baroness Cumberlege’s independent medicines and medical devices safety review. I thank Baroness Cumberlege and her team for their work, and of course the women who bravely shared their horrific experiences, which shone a light on the horrors of the mesh scandal. Without their bravery, the review would not have been possible.

It is vital that the Government continue to listen to the victims who were ignored for far too long. I was glad to hear reassurances from the Minister, following the publication of the report, that the Department is committed to doing so. I was proud to support the Medicines and Medical Devices Act 2021, part 1 of which established the role of an independent commissioner for patient safety and states:

“The Commissioner’s core duties are to…promote the safety of patients”.

If that prevents the repetition of any one of the mistakes from the past, it will have reduced pain and suffering for our constituents, and it will have done its job.

In my time as a high street solicitor, I acted on behalf of a number of clients who experienced horrific difficulties as a result of mesh implants, like those so clearly outlined by my right hon. Friend the Member for Elmet and Rothwell (Alec Shelbrooke). The trauma that mesh patients underwent was truly horrendous, and it is shameful that it took so long for action to be taken and for women’s voices to be heard.

I welcomed the announcement in February by NHS England and NHS Improvement’s women and children’s programme of care that it is commissioning specialist services for women with complications with mesh inserts. The regional centres will ensure that women receive specialist treatment to mitigate this awful suffering. I encourage County Durham and Darlington NHS Foundation Trust to ensure that its patients access the appropriate treatment applicable for the mesh implants they have and to get access to the justice they deserve.

Baroness Cumberlege’s review was a powerful reminder of the need to listen to patient voices in safety matters. I am glad that the Department of Health and Social Care has offered an unreserved apology for its mistakes in the past, and welcome the steps that it has taken so far to build on the report’s recommendations. I look forward to the Minister outlining any further response to Baroness Cumberlege’s report.

[Madam Deputy Speaker (Dame Eleanor Laing)]

I thank the hon. Gentleman most profusely for his brevity.

Covid-19: Contracts and Public Inquiry

Eleanor Laing Excerpts

Wednesday 7th July 2021 Commons Chamber

[Fleur Anderson]

Inquiries need to happen in real time, as we are learning, because we are making decisions all the time that affect our lives. There also need to be major Government inquiries, and I hope that all of this will be included in the Government inquiry to come.

The Minister made much of the Boardman review, saying, “There has been an inquiry. Don’t worry. The Boardman review has done it,” but this is my thirteenth question. It is, again, a question that I have asked before and received no answer to: does she seriously believe that the Boardman review is an independent and unbiased review, and good enough? How can she think that when Mr Boardman’s law firm has been the recipient of Government contracts in the past year, and given that Mr Boardman once ran to be a Conservative councillor—far more than just voting for one party or another? It looks more and more as if the Conservatives are set on glossing over the cronyism in their ranks, so that they can carry on as if nothing has happened.

I have two more questions, and then I will close. Question 14: when will we see a return of all public sector procurement to open competitive contracting as a default? The Minister said that emergency procurement procedures are still continuing, but they do not need to anymore. We need a way of having a contract in good time but with all the open competitiveness that the public need to see. There is no justification for the continuation of emergency procedures. They should be wound down immediately, and ways found to make contracting work without being secretive.

Finally, my fifteenth question: where is the Chancellor of the Duchy of Lancaster to answer these questions? The Cabinet Office is responsible for overseeing transparency across Government, and these are the fundamental questions that we have today. Why has he once again dodged an opportunity to explain the decisions made by his Department? Will he ever take responsibility and stop getting other Ministers to do his explaining for him, as has happened in many previous debates on this issue? The public will not stop asking these questions. We on the Opposition Benches will not stop asking these questions. We need some answers.

I have a lot of sympathy for the Minister, who will have to field some incredibly difficult questions about serious allegations. When such debates come up I can imagine that the conversation that Ministers have about who will reply is not a pleasant one. There are some very serious allegations, and I hope to hear the answers this afternoon.

[Madam Deputy Speaker (Dame Eleanor Laing)]

I hope that we can manage the debate without a time limit. We will do so if everyone takes around six minutes. That will mean plenty of time for interventions and real debate.

--- Later in debate ---

[Mr Carmichael]

Actually no: it is not an either/or. I think it is eminently possible to have a quick and dirty analysis. In fact, given that we may be looking at further waves, vaccine resistance and the rest of it, I think it is very important that we do have an early analysis of some of the public health aspects. However, that should not be a barrier to a fuller and more thorough analysis of things when we have the full facts available to us. As I say, other public inquiries have proceeded in that way, and I see no reason why this one should not.

The reason why I think it is particularly important that we have an early start is that, as we read in many of the newspapers, the Government’s intention is possibly to go to the country in a general election as early as 2023. An inquiry that starts now might have a fighting chance of bringing at least preliminary decisions to this House and to the public before that point. One that starts in the spring of next year—we know that spring is a moveable feast in Government calendars—will almost certainly still be doing its work when it comes to a general election in 2023, if that is when we get it.

The point is that, in March last year, this House gave a lot of power to the Executive—unprecedented amounts of power. Those powers for the most part, actually, have been unused, but still the Government insist on holding on to them, because that is in the nature of Governments. Once Parliament gives power to the Executive, the Executive are always very reluctant to give it back. We can go back as far as the granting of the power to force people to carry identity cards in 1939. We might have thought that that would finish in 1945, but in fact it was the early 1950s before a court ruled that the emergency had passed and the carrying of identity cards was no longer necessary.

I also want this inquiry to look at what the decision-making process was to ensure that we continued with these emergency powers, because I would suggest that the moment had probably passed in September of last year and had almost certainly passed by March of this year when we renewed them for the second time. So there are questions that can be answered now. They must be answered now, and it is in the interests of politics and the standing of this place that they should be answered now.

[Madam Deputy Speaker (Dame Eleanor Laing)]

I hope that Members will now keep their speeches to under five minutes, because then everybody will get a chance to speak.

NHS Integrated Care System Boundaries

Eleanor Laing Excerpts

Tuesday 29th June 2021 Commons Chamber

[Edward Argar]

I would try to address that point briefly, but I think my hon. Friend would rather have the reassurance that I can give him. Perhaps I can pick up that point separately with him, because I do not want to run out of time.

Finally, and most importantly, I reassure my hon. Friend and other Members that no decisions have yet been made regarding the outcome of the ICS boundary review. As he would expect, the newly appointed Secretary of State will want to consider carefully the background to this issue, the options before him and, indeed, the views of right hon. and hon. Members before any decision is made. I have discussed this matter with the new Secretary of State and wish to extend his clear commitment to meet my hon. Friend, my right hon. Friend the Member for Maidenhead and other Members before he makes any decision and decides how to proceed in this matter.

My hon. Friend knows me well, and my preference is generally for evolution, not revolution. I hope that, him knowing me well and in the light of what I have said today, he will recognise the sincerity of what I say. I also hope it is helpful that I have put on record, once again, that no decisions have been made and that Members will be consulted and have the opportunity to speak to the Secretary of State. I hope that commitment reassures my hon. Friend, at least in the short term, that nothing will happen without him and other Members having their say clearly on the record.

[Madam Deputy Speaker (Dame Eleanor Laing)]

I normally thank the Minister politely at this point in the day, but I really do thank the Minister for what he has just said on this particular occasion.

[Jim Shannon]

On a point of order, Madam Deputy Speaker. Earlier, you announced the excellent, historic victory of England over Germany. How can I record my congratulations to the English team on behalf of all the people of Northern Ireland, not just in my constituency of Strangford but across from Newry to Londonderry and from Portrush to Enniskillen, where the Union flags are flying? I have one flying at the end of my farm lane. It could be that those flags are flying in celebration of the forthcoming 12 July celebrations, but I believe that they are flying to support England, so how can we send our support from Northern Ireland and wish England well for the quarter finals and for this competition? Our team, England, are playing in the quarter finals, and that has got to be good news.

--- Later in debate ---

[Madam Deputy Speaker]

I think the hon. Gentleman has just done what he was endeavouring to do. I fully understand his position. As one who supports Scotland whenever I can, I am absolutely delighted to be totally, enthusiastically in support of England going forward.

Question put and agreed to.

Miscarriage Research: The Lancet

Eleanor Laing Excerpts

Thursday 17th June 2021 Commons Chamber

[Madam Deputy Speaker (Dame Eleanor Laing)]

I would like to thank the Minister for the sensitive way in which she has responded to the great courage that the hon. Member for Sheffield, Hallam (Olivia Blake) has shown in bringing this subject to the Chamber. Most of us have never dared to raise these matters here because we know the reaction that we would previously have got, but now we have made a difference, and the hon. Lady and the Minister have made a big difference today in treating this matter with the seriousness it deserves here in this Chamber.

Question put and agreed to.